Description: Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Home Page: www.apolloendo.com
APEN Technical Analysis
Building 1
Austin,
TX
78746
United States
Phone:
512 279 5100
Officers
Name | Title |
---|---|
Mr. Charles S. McKhann | CEO, Pres & Director |
Mr. Jeffrey G. Black | CFO, Sec. & Treasurer |
Mr. John J. Molesphini | Exec. VP of Operations |
Dr. Sergey Kantsevoy M.D. | Co-Founder and Innovation Partner |
Mr. Anthony Kalloo M.D. | Co-Founder and Innovation Partner |
Dr. Robert Hawes M.D. | Co-Founder and Innovation Partner |
Dr. Peter Benjamin Cotton M.D. | Co-Founder and Innovation Partner |
Dr. Christopher J. Gostout M.D. | Co-Founder & Chief Medical Officer |
Mr. Sydney Chung M.D. | Co-Founder and Innovation Partner |
Dr. Pankaj Jay Pasricha FACP, M.D., MBBS | Co-Founder |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 9.7761 |
Price-to-Sales TTM: | 5.78 |
IPO Date: | 2005-12-09 |
Fiscal Year End: | December |
Full Time Employees: | 202 |